| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| foundationone cdx cpt code | 1.23 | 0.3 | 9968 | 16 | 26 |
| foundationone | 0.92 | 0.5 | 2163 | 23 | 13 |
| cdx | 1.26 | 0.3 | 9778 | 16 | 3 |
| cpt | 0.33 | 0.2 | 9757 | 48 | 3 |
| code | 0.76 | 0.1 | 5079 | 32 | 4 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| foundationone cdx cpt code | 0.48 | 0.6 | 9571 | 49 |
| foundationone liquid cdx cpt code | 1.72 | 0.3 | 9397 | 97 |
| cpt code for foundationone liquid cdx test | 1.76 | 0.7 | 5055 | 36 |
| foundation cdx cpt code | 1.47 | 0.4 | 7132 | 13 |
| foundationone cdx technical information | 1.76 | 0.3 | 4347 | 85 |
| foundation one cpt code | 0.13 | 0.9 | 7080 | 85 |
| foundationone cdx medical policy | 0.33 | 0.7 | 8238 | 83 |
| foundationone cdx fda approval | 0.94 | 0.8 | 6528 | 65 |
| foundation one testing cpt code | 0.28 | 0.8 | 1003 | 7 |
| foundationone liquid cdx fda approval | 1 | 0.2 | 1234 | 51 |
| foundationone liquid cdx fda | 1.95 | 1 | 7644 | 60 |
| foundationone cdx gene list | 1.11 | 0.5 | 9997 | 34 |
| foundation medicine cpt code | 1.15 | 0.5 | 6450 | 19 |
| foundation one cdx fda | 0.08 | 0.1 | 9469 | 5 |
| foundationone liquid cdx test | 1.7 | 0.3 | 1490 | 7 |
| foundation one cdx test | 1.7 | 0.2 | 3938 | 73 |
| foundation one cdx testing | 1.9 | 0.4 | 884 | 13 |
| foundationone liquid cdx gene list | 1.52 | 0.4 | 7638 | 70 |
| foundation one cdx order form | 1.57 | 0.3 | 7898 | 56 |
The FoundationOne Liquid CDx test is used to test the blood of patients with metastatic castration resistant prostate cancer or non-small cell lung cancer.
Does Medicare cover FoundationOne CDx?Medicare covers FoundationOne®CDx, FoundationOne®Liquid CDx, and FoundationOne®Heme for qualifying patients. FoundationOne CDx is also covered by TRICARE for qualifying patients. FoundationOne Heme has limited commercial health plan coverage at this time.
What are the indications for the f1cdx test?This approval expands the indications for use of the F1CDx test to include an additional companion diagnostic indication for solid tumor patients who have gene rearrangements that can lead to fusions of the genes NTRK1, NTKR2, and NTRK3.
Is financial assistance available for Foundation Medicine testing?Financial assistance is available for qualifying patients in the United States (US) who have out-of-pocket costs associated with Foundation Medicine testing. Financial assistance is based on need and can be applied for at any point during the testing process. Payment plans may also be available.
